Advertisement

Cannabinoid/Endocannabinoid Signaling Impact on Early Pregnancy Events

  • Xiaofei Sun
  • Sudhansu K. DeyEmail author
Chapter
Part of the Current Topics in Behavioral Neurosciences book series (CTBN, volume 1)

Abstract

It has been known for decades that marijuana and its major psychoactive component Δ9-tetrahydrocannabinol (THC) alter both male and female reproductive functions in humans and laboratory animals. The discovery of cannabinoid-like molecules (endocannabinoids), anandamide (AEA) and 2-arachidonylglycerol (2AG), as well as G-protein-coupled cannabinoid/endocannabinoid receptors CB1 and CB2, created an opportunity to study the adverse and beneficial effects of cannabinoids/endocannabinoids on fertility using molecular, physiological and genetic approaches. In fact, studies to explore the significance of cannabinoid/endocannabinoid signaling in reproduction have revealed some intriguing physiological roles in early pregnant events. This review summarizes some aspects of these signaling molecules in preimplantation and implantation biology utilizing genetically engineered mouse models.

Keywords

Endocannaibnoids CB1 CB2 Pregnancy Implantation Uterus Oviduct 

Notes

Acknowledgements

The authors thank Susanne Tranguch for her critical reading of the manuscript. This work was supported in part by NIH grants DA06668, HD12304, and P01-CA-77,839. S. K. Dey is a recipient of Method to Extend Research in Time (MERIT) Awards from the National Institute on Drug Abuse (NIDA) and the National Institute of Child Health and Human Development (NICHD).

References

  1. Abma JC, Chandra A, Mosher WD et al. (1997) Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital Health Stat 19:1–114Google Scholar
  2. Baker D, Pryce G, Davies WL et al. (2006) In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci 27:1–4PubMedCrossRefGoogle Scholar
  3. Beltramo M, Piomelli D (2000) Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11:1231–1235PubMedCrossRefGoogle Scholar
  4. Bisogno T, Sepe N, Melck D et al. (1997) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322(Pt 2):671–677PubMedGoogle Scholar
  5. Bisogno T, Howell F, Williams G et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463–468PubMedCrossRefGoogle Scholar
  6. Bouaboula M, Poinot-Chazel C, Bourrie B et al. (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312(Pt 2):637–641PubMedGoogle Scholar
  7. Bracey MH, Hanson MA, Masuda KR et al. (2002) Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science (New York, NY) 298:1793–1796CrossRefGoogle Scholar
  8. Carson DD, Bagchi I, Dey SK et al. (2000) Embryo implantation. Dev Biol 223:217–237PubMedCrossRefGoogle Scholar
  9. Caulfield MP, Brown DA (1992) Cannabinoid receptor agonists inhibit Ca current in NG108–15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol 106:231–232PubMedGoogle Scholar
  10. Cravatt BF, Lichtman AH (2002) The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem Phys Lipids 121:135–148PubMedCrossRefGoogle Scholar
  11. Cravatt BF, Giang DK, Mayfield SP et al. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83–87PubMedCrossRefGoogle Scholar
  12. Cross JC, Werb Z, Fisher SJ (1994) Implantation and the placenta: key pieces of the development puzzle. Science (New York, NY) 266:1508–1518CrossRefGoogle Scholar
  13. Das SK, Wang XN, Paria BC et al. (1994) Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development (Cambridge, England) 120:1071–1083Google Scholar
  14. Das SK, Paria BC, Chakraborty I et al. (1995) Cannabinoid ligand–receptor signaling in the mouse uterus. Proc Natl Acad Sci USA 92:4332–4336PubMedCrossRefGoogle Scholar
  15. De Petrocellis L, Bisogno T, Maccarrone M et al. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276:12856–12863PubMedCrossRefGoogle Scholar
  16. Devane WA, Dysarz FA 3rd, Johnson MR et al. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613PubMedGoogle Scholar
  17. Devane WA, Hanus L, Breuer A et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (New York, NY) 258:1946–1949CrossRefGoogle Scholar
  18. Dey SK, Lim H, Das SK et al. (2004) Molecular cues to implantation. Endocr Rev 25:341–373PubMedCrossRefGoogle Scholar
  19. Dinh TP, Carpenter D, Leslie FM et al. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99:10819–10824PubMedCrossRefGoogle Scholar
  20. Evans JP, Florman HM (2002) The state of the union: the cell biology of fertilization. Nature Cell Biol 4(Suppl):s57–s63PubMedCrossRefGoogle Scholar
  21. Farquhar CM (2005) Ectopic pregnancy. Lancet 366:583–591PubMedCrossRefGoogle Scholar
  22. Gaddum-Rosse P, Blandau RJ (1976) Comparative observations on ciliary currents in mammalian oviducts. Biol Reprod 14:605–609PubMedCrossRefGoogle Scholar
  23. Gaoni Y, Mechoulam R (1964) Isolation, structure, and partial synthesis of an active constituent of Hashish. J Am Chem Soc 86:1646–1647CrossRefGoogle Scholar
  24. Gebremedhin D, Lange AR, Campbell WB et al. (1999) Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol 276:H2085–H2093PubMedGoogle Scholar
  25. Giang DK, Cravatt BF (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA 94:2238–2242PubMedCrossRefGoogle Scholar
  26. Glaser ST, Kaczocha M, Deutsch DG (2005) Anandamide transport: a critical review. Life Sci 77:1584–1604PubMedCrossRefGoogle Scholar
  27. Goparaju SK, Ueda N, Taniguchi K et al. (1999) Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol 57:417–423PubMedCrossRefGoogle Scholar
  28. Guo Y, Wang H, Okamoto Y et al. (2005) N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem 280:23429–23432PubMedCrossRefGoogle Scholar
  29. Halbert SA, Tam PY, Blandau RJ (1976) Egg transport in the rabbit oviduct: the roles of cilia and muscle. Science (New York, NY) 191:1052–1053CrossRefGoogle Scholar
  30. Hamatani T, Daikoku T, Wang H et al. (2004) Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. Proc Natl Acad Sci U S A 101:10326–10331PubMedCrossRefGoogle Scholar
  31. Heilman RD, Reo RR, Hahn DW (1976) Changes in the sensitivity of adrenergic receptors in the oviduct during early gestation in the rabbit. Fertil Steril 27:426–430PubMedGoogle Scholar
  32. Ho SY, Delgado L, Storch J (2002) Monoacylglycerol metabolism in human intestinal Caco-2 cells: evidence for metabolic compartmentation and hydrolysis. J Biol Chem 277:1816–1823PubMedCrossRefGoogle Scholar
  33. Howe GR, Black DL (1973) Autonomic nervous system and oviduct function in the rabbit. I. Hormones and contraction. Journal Reprod Fertil 33:425–430CrossRefGoogle Scholar
  34. Howlett AC, Barth F, Bonner TI et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161–202PubMedCrossRefGoogle Scholar
  35. Kaczocha M, Hermann A, Glaser ST et al. (2006) Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. J Biol Chem 281:9066–9075PubMedCrossRefGoogle Scholar
  36. Lauckner JE, Hille B, Mackie K (2005) The cannabinoid agonist WIN55, 212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc Natl Acad Sci USA 102:19144–19149PubMedCrossRefGoogle Scholar
  37. Leung D, Saghatelian A, Simon GM et al. (2006) Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45:4720–4726PubMedCrossRefGoogle Scholar
  38. Liu J, Wang L, Harvey-White J et al. (2006) A biosynthetic pathway for anandamide. Proc Natl Acad Sci USA 103:13345–13350PubMedCrossRefGoogle Scholar
  39. Maccarrone M, Finazzi-Agro A (2003) The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 10:946–955PubMedCrossRefGoogle Scholar
  40. Maccarrone M, Valensise H, Bari M et al. (2000) Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355:1326–1329PubMedCrossRefGoogle Scholar
  41. Maccarrone M, Bisogno T, Valensise H et al. (2002) Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Molecular Human Reprod 8:188–195CrossRefGoogle Scholar
  42. Maccarrone M, DeFelici M, Klinger FG et al. (2004) Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus. Molecular Human Reprod 10:215–221CrossRefGoogle Scholar
  43. Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825–3829PubMedCrossRefGoogle Scholar
  44. Matas D, Juknat A, Pietr M et al. (2007) Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine. J Biol Chem 282:7885–7892PubMedCrossRefGoogle Scholar
  45. Matsuda LA, Lolait SJ, Brownstein MJ et al. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564PubMedCrossRefGoogle Scholar
  46. McAllister SD, Glass M (2002) CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 66:161–171PubMedCrossRefGoogle Scholar
  47. McKinney MK, Cravatt BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411–432PubMedCrossRefGoogle Scholar
  48. McLaren A (1971) Blastocysts in the mouse uterus: the effect of ovariectomy, progesterone and oestrogen. J Endocrinol 50:515–526PubMedCrossRefGoogle Scholar
  49. McPartland JM, Matias I, Di Marzo V et al. (2006) Evolutionary origins of the endocannabinoid system. Gene 370:64–74CrossRefGoogle Scholar
  50. Mechoulam R, Deutsch DG (2005) Toward an anandamide transporter. Proc Natl Acad Sci U S A 102:17541–17542PubMedCrossRefGoogle Scholar
  51. Mechoulam R, Hanus L (2000) A historical overview of chemical research on cannabinoids. Chem Phys Lipids 108:1–13PubMedCrossRefGoogle Scholar
  52. Mechoulam R, Ben-Shabat S, Hanus L et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83–90PubMedCrossRefGoogle Scholar
  53. Moriyama T, Urade R, Kito M (1999) Purification and characterization of diacylglycerol lipase from human platelets. J Biochem 125:1077–1085PubMedGoogle Scholar
  54. Muccioli GG, Xu C, Odah E et al. (2007) Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci 27:2883–2889PubMedCrossRefGoogle Scholar
  55. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65PubMedCrossRefGoogle Scholar
  56. Murphy LO, Blenis J (2006) MAPK signal specificity: the right place at the right time. Trends Biochem Sci 31:268–275PubMedCrossRefGoogle Scholar
  57. Natarajan V, Reddy PV, Schmid PC et al. (1982) N-Acylation of ethanolamine phospholipids in canine myocardium. Biochim Biophys Acta 712:342–355PubMedGoogle Scholar
  58. Natarajan V, Schmid PC, Reddy PV et al. (1984) Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J Neurochem 42:1613–1619PubMedCrossRefGoogle Scholar
  59. Okamoto Y, Morishita J, Tsuboi K et al. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298–5305PubMedCrossRefGoogle Scholar
  60. Ortega-Gutierrez S (2005) Therapeutic perspectives of inhibitors of endocannabinoid degradation. Curr Drug Targets 4:697–707Google Scholar
  61. Paria BC, Huet-Hudson YM, Dey SK (1993) Blastocyst's state of activity determines the "window" of implantation in the receptive mouse uterus. Proc Natl Acad Sci USA 90:10159–10162PubMedCrossRefGoogle Scholar
  62. Paria BC, Das SK, Dey SK (1995) The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc Natl Acad Sci USA 92:9460–9464PubMedCrossRefGoogle Scholar
  63. Paria BC, Lim H, Wang XN et al. (1998a) Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology 139:5235–5246PubMedCrossRefGoogle Scholar
  64. Paria BC, Ma W, Andrenyak DM et al. (1998b) Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod 58:1490–1495PubMedCrossRefGoogle Scholar
  65. Paria BC, Song H, Wang X et al. (2001) Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem 276:20523–20528PubMedCrossRefGoogle Scholar
  66. Paria BC, Reese J, Das SK et al. (2002) Deciphering the cross-talk of implantation: advances and challenges. Science (New York, NY) 296:2185–2188CrossRefGoogle Scholar
  67. Pertwee RG, Ross RA (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66:101–121PubMedCrossRefGoogle Scholar
  68. Piomelli D (2004) THC: moderation during implantation. Nat Med 10:19–20PubMedCrossRefGoogle Scholar
  69. Pisarska MD, Carson SA, Buster JE (1998) Ectopic pregnancy. Lancet 351:1115–1120PubMedCrossRefGoogle Scholar
  70. Red-Horse K, Zhou Y, Genbacev O et al. (2004) Trophoblast differentiation during embryo implantation and formation of the maternal–fetal interface. J Clin Invest 114:744–754PubMedGoogle Scholar
  71. Rossant J (2004) Lineage development and polar asymmetries in the peri-implantation mouse blastocyst. Semin Cell Develop Biol 15:573–581CrossRefGoogle Scholar
  72. Rossant J, Tam PP (2004) Emerging asymmetry and embryonic patterning in early mouse development. Develop Cell 7:155–164CrossRefGoogle Scholar
  73. Sawzdargo M, Nguyen T, Lee DK et al. (1999) Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64:193–198PubMedCrossRefGoogle Scholar
  74. Schmid PC, Paria BC, Krebsbach RJ et al. (1997) Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci USA 94:4188–4192PubMedCrossRefGoogle Scholar
  75. Shah BH, Catt KJ (2005) Roles of LPA3 and COX-2 in implantation. Trends Endocrinol Metab 16:397–399PubMedCrossRefGoogle Scholar
  76. Sharov AA, Piao Y, Matoba R et al. (2003) Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol 1:E74PubMedCrossRefGoogle Scholar
  77. Simon GM, Cravatt BF (2006) Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 281:26465–26472PubMedCrossRefGoogle Scholar
  78. Song H, Lim H, Paria BC et al. (2002) Cytosolic phospholipase A2alpha is crucial [correction of A2alpha deficiency is crucial] for ‘on-time’ embryo implantation that directs subsequent development. Development (Cambridge, England) 129:2879–2889Google Scholar
  79. Sugiura T, Kudo N, Ojima T et al. (1995) Coenzyme A-dependent cleavage of membrane phospholipids in several rat tissues: ATP-independent acyl-CoA synthesis and the generation of lysophospholipids. Biochim Biophys Acta 1255:167–176PubMedGoogle Scholar
  80. Sugiura T, Kishimoto S, Oka S et al. (2006) Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res 45:405–446PubMedCrossRefGoogle Scholar
  81. Sun X, Dey SK (2008) Aspects of endocannabinoid signaling in periimplantation biology. Mol Cell Endocrinol 286(1–2):S3–S11PubMedCrossRefGoogle Scholar
  82. Thonneau P, Marchand S, Tallec A et al. (1991) Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988–1989). Human Reprod (Oxford, England) 6:811–816Google Scholar
  83. Ueda N, Liu Q, Yamanaka K (2001) Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations. Biochim Biophys Acta 1532:121–127PubMedGoogle Scholar
  84. Van Der Stelt M, Di Marzo V (2004) Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem/FEBS 271:1827–1834CrossRefGoogle Scholar
  85. Wang H, Dey SK. Unpublished dataGoogle Scholar
  86. Wang H, Dey SK (2005) Lipid signaling in embryo implantation. Prostag Oth Lipid M 77:84–102CrossRefGoogle Scholar
  87. Wang H, Dey SK (2006) Roadmap to embryo implantation: clues from mouse models. Nature Rev 7:185–199CrossRefGoogle Scholar
  88. Wang J, Paria BC, Dey SK et al. (1999) Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. Biol Reprod 60:839–844PubMedCrossRefGoogle Scholar
  89. Wang H, Matsumoto H, Guo Y et al. (2003) Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc Natl Acad Sci U S A 100:14914–14919PubMedCrossRefGoogle Scholar
  90. Wang H, Guo Y, Wang D et al. (2004) Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med 10:1074–1080PubMedCrossRefGoogle Scholar
  91. Wang H, Dey SK, Maccarrone M (2006a) Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev 27:427–448PubMedCrossRefGoogle Scholar
  92. Wang H, Xie H, Guo Y et al. (2006b) Fatty acid amide hydrolase deficiency limits early pregnancy events. J Clin Invest 116:2122–2131PubMedCrossRefGoogle Scholar
  93. Wang H, Xie H, Sun X et al. (2007) Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostag Oth Lipid M 83:62–74CrossRefGoogle Scholar
  94. Wassarman PM, Jovine L, Litscher ES (2001) A profile of fertilization in mammals. Nat Cell Biol 3:E59–E64PubMedCrossRefGoogle Scholar
  95. Wei BQ, Mikkelsen TS, McKinney MK et al. (2006) A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem 281:36569–36578PubMedCrossRefGoogle Scholar
  96. Wilcox AJ, Weinberg CR, O'Connor JF et al. (1988) Incidence of early loss of pregnancy. N Engl J Med 319:189–194PubMedCrossRefGoogle Scholar
  97. Yang ZM, Paria BC, Dey SK (1996) Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol Reprod 55:756–761PubMedCrossRefGoogle Scholar
  98. Ye X, Hama K, Contos JJ et al (2005) LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435:104–108PubMedCrossRefGoogle Scholar
  99. Yoshinaga K, Adams CE (1966) Delayed implantation in the spayed, progesterone treated adult mouse. J Reprod Fertil 12:593–595PubMedCrossRefGoogle Scholar
  100. Zernicka-Goetz M (2005) Cleavage pattern and emerging asymmetry of the mouse embryo. Nat Rev Mol Cell Biol 6:919–928PubMedCrossRefGoogle Scholar
  101. Zoratti C, Kipmen-Korgun D, Osibow K et al. (2003) Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells. Br J Pharmacol 140:1351–1362PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.Reproductive SciencesCincinnati Children’s Hospital Research FoundationCincinnatiUSA

Personalised recommendations